Diagnostic imaging of hepatocellular carcinoma at community hospitals and their tertiary referral center in the era of LI-RADS: a quality assessment study

被引:3
|
作者
Chan, Andrew [1 ]
Sertic, Madeleine [1 ]
Sammon, Jennifer [1 ,2 ]
Kim, Tae Kyoung [1 ,2 ]
Jang, Hyun-Jung [1 ,2 ]
Guimaraes, Luis [1 ,2 ]
O'Malley, Martin [1 ,2 ]
Khalili, Korosh [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada
[2] Univ Hlth Network, Womens Coll Hosp, Joint Dept Med Imaging, Sinai Hlth Syst, Toronto, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Joint Dept Med Imaging, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
关键词
Hepatocellular carcinoma; Diagnosis; Quality; Liver; CT; MRI; LI-RADS; RELIABILITY; CRITERIA; VERSION; TUMOR;
D O I
10.1007/s00261-019-02237-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To assess guideline compliance and quality of hepatocellular carcinoma, (HCC) diagnostic imaging within community hospitals (CH) and their Tertiary referral center (TRC) in a moderately high incidence region. Methods Initial diagnostic workup CT/MRI scans of 251 patients (122 CH, 112 TRC, 17 Non-TRC academic) with HCC over a 15-month period were assessed for Liver reporting and Data System (LI-RADS) guideline compliance. 269 scans (182 CT, 87 MRI) were qualitatively evaluated by 2 independent blinded radiologists for arterial timing, overall image quality, noise and sharpness, with quantification of interobserver variability. The contrast enhancement ratio (CER) for the largest HCC on each scan was calculated using pre- and post-contrast images. Results 103/104 (99%) of TRC and 44/78 (56%) of CH CTs adhered to LI-RADS imaging guidelines (P < 0.0001). Lack of delayed phase accounted for 32/34 (94%) of noncompliant CH CTs. Regarding MRI, 19/19 (100%) of TRC and 60/68 (88%) of CH scans were adherent (P = 0.12). For both modalities, overall image quality, noise and sharpness were rated significantly higher for TRC than CH. There was moderate interobserver agreement with intraclass correlation coefficient of 0.73, 0.70 and 0.63, respectively. Arterial-phase timing was rated adequate for CT in 75/104 TRC (72%) and 10/68 (14%) CH scans (P < 0.0001) and for MRI in 8/19 (42%) TRC and 23/68 (33%) CH scans (P = 0.17). The CER was significantly higher for TRC versus CH (2.9 vs. 1.9, P < 0.001) and MRI (0.9 vs. 0.7, P = 0.03). Conclusions Community hospital HCC diagnostic scans significantly lag in critical quality parameters of tumor enhancement, arterial phase timing, perceived image quality, and LI-RADS CT technique compliance compared to a TRC.
引用
收藏
页码:4028 / 4036
页数:9
相关论文
共 50 条
  • [1] Diagnostic imaging of hepatocellular carcinoma at community hospitals and their tertiary referral center in the era of LI-RADS: a quality assessment study
    Andrew Chan
    Madeleine Sertic
    Jennifer Sammon
    Tae Kyoung Kim
    Hyun-Jung Jang
    Luis Guimaraes
    Martin O’Malley
    Korosh Khalili
    Abdominal Radiology, 2019, 44 : 4028 - 4036
  • [2] Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS
    Liu, Weimin
    Qin, Jie
    Guo, Ruomi
    Xie, Sidong
    Jiang, Hang
    Wang, Xiaohong
    Kang, Zhuang
    Wang, Jin
    Shan, Hong
    ACTA RADIOLOGICA, 2018, 59 (02) : 140 - 146
  • [3] Optimizing diagnostic imaging data using LI-RADS and the Likert scale in patients with hepatocellular carcinoma
    Morad, Kholoud
    Moustafa, Amr F.
    Refaat, Amal M.
    AbdEllatif, Ahmed
    ElAzab, Mohammed S.
    POLISH JOURNAL OF RADIOLOGY, 2021, 86 : E557 - E563
  • [4] Imaging diagnosis of hepatocellular carcinoma: LI-RADS
    Cunha, Guilherme Moura
    Sirlin, Claude B.
    Fowler, Kathryn J.
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (01)
  • [5] Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma
    Kierans, Andrea S.
    Song, Christopher
    Gavlin, Alexander
    Roudenko, Alexandra
    Lu, Lina
    Askin, Gulce
    Hecht, Elizabeth M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (05) : 1085 - 1092
  • [6] Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
    Cannella, Roberto
    Burgio, Marco Dioguardi
    Beaufrere, Aurelie
    Trapani, Loic
    Paradis, Valerie
    Hobeika, Christian
    Cauchy, Francois
    Bouattour, Mohamed
    Vilgrain, Valerie
    Sartoris, Riccardo
    Ronot, Maxime
    JHEP REPORTS, 2021, 3 (06)
  • [7] Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
    Ahmed Haitham Abduljabbar
    Mohammad A. Wazzan
    Egyptian Journal of Radiology and Nuclear Medicine, 54
  • [8] Diagnostic performance of US LI-RADS in hepatocellular carcinoma surveillance
    Abduljabbar, Ahmed Haitham
    Wazzan, Mohammad A.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2023, 54 (01)
  • [9] Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma
    Kierans, Andrea S.
    Makkar, Jasnit
    Guniganti, Preethi
    Cornman-Homonoff, Joshua
    Lee, Michael J.
    Pittman, Meredith
    Askin, Gulce
    Hecht, Elizabeth M.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (07) : E205 - E215
  • [10] Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
    Voizard, Nicolas
    Cerny, Milena
    Assad, Anis
    Billiard, Jean-Sebastien
    Olivie, Damien
    Perreault, Pierre
    Kielar, Ania
    Do, Richard K. G.
    Yokoo, Takeshi
    Sirlin, Claude B.
    Tang, An
    INSIGHTS INTO IMAGING, 2019, 10 (01)